To further confirm a role for SIRT6 in melanoma drug resistance, we generated SKMel-239 MAPKi-resistant cells by prolonged drug treatment37, and observed decreased SIRT6 levels in all resistant clones (Fig. 1e), indicating that lower levels of SIRT6 are associated with acquired resistance. The gene discussed is SIRT6; the disease is melanoma.